{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:29:08Z","timestamp":1790713748940,"version":"4.1.0"},"reference-count":107,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ejinme.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.ejim.2013.09.006","type":"journal-article","created":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T07:22:25Z","timestamp":1380612145000},"page":"117-124","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["Gaucher disease: A diagnostic challenge for internists"],"prefix":"10.1016","volume":"25","author":[{"given":"Elena","family":"Cassinerio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Graziadei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Poggiali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2013.09.006_bb0540","series-title":"De l'epithelioma primitive de la rate, hypertrophie idiopathique de la rate sans leucemie","author":"Gaucher","year":"1882"},{"key":"10.1016\/j.ejim.2013.09.006_bb0010","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/00000441-190503000-00014","article-title":"Primary splenomegaly-Gaucher type. Report on one of four cases occurring in a single generation in one family","volume":"129","author":"Brill","year":"1905","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.ejim.2013.09.006_bb0015","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1146\/annurev.bi.60.070191.001353","article-title":"Lysosomal storage disease","volume":"60","author":"Neufeld","year":"1991","journal-title":"Ann Rev Biochem"},{"key":"10.1016\/j.ejim.2013.09.006_bb0020","first-page":"219","article-title":"Glucosylceramide and related compounds in normal tissue and in Gaucher disease","volume":"95","author":"Suzuki","year":"1982","journal-title":"Prog Clin Biol Res"},{"key":"10.1016\/j.ejim.2013.09.006_bb0025","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1136\/jmg.30.11.889","article-title":"The glucocerebrosidase locus in Gaucher's disease: molecular analysis of a lysosomal enzyme","volume":"30","author":"Mistry","year":"1993","journal-title":"J Med Genet"},{"key":"10.1016\/j.ejim.2013.09.006_bb0030","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/humu.9058","article-title":"Analysis of the glucocerebrosidase gene and mutation profile in 144 Italian Gaucher patients","volume":"20","author":"Filocamo","year":"2002","journal-title":"Hum Mutat"},{"key":"10.1016\/j.ejim.2013.09.006_bb0035","series-title":"The metabolic basis of inherited disease","article-title":"Glucosylceramide lipidoses: Gaucher disease","author":"Barranger","year":"1989"},{"key":"10.1016\/j.ejim.2013.09.006_bb0040","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1007\/s10545-009-1164-2","article-title":"Management of neuronopathic Gaucher disease: revised recommendations","volume":"32","author":"Vellodi","year":"2009","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.ejim.2013.09.006_bb0045","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1016\/S0021-9258(17)42166-1","article-title":"Analysis of human acid \u03b2-glucosidase by site-directed mutagenesis and heterogeneous expression","volume":"269","author":"Grace","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ejim.2013.09.006_bb0050","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.bcmd.2004.03.001","article-title":"Phosphatidylcholine metabolism is altered in a monocyte-derived macrophage model of Gaucher disease but not in lymphocytes","volume":"33","author":"Trajkovic-Bodennec","year":"2004","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.ejim.2013.09.006_bb0055","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1365-2141.2004.05351.x","article-title":"Gaucher disease: pathological mechanisms and modern management","volume":"129","author":"Jmudiak","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ejim.2013.09.006_bb0060","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.5858\/2004-128-1191-EIGC","article-title":"Erythrophagocytosis in Gaucher cells","volume":"128","author":"Bitton","year":"2004","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.ejim.2013.09.006_bb0065","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1309\/BG5VA8JRDQH1M7HN","article-title":"Gaucher cells demonstrate a distinct macrophage phenotype and resemble alternatively activated macrophages","volume":"122","author":"Boven","year":"2004","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.ejim.2013.09.006_bb0070","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0925-4439(96)00056-7","article-title":"Plasma tumour necrosis factor-a (TNF-a) level in Gaucher disease","volume":"1317","author":"Michelakakis","year":"1996","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.ejim.2013.09.006_bb0075","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/qjmed\/90.1.19","article-title":"Pro-inflammatory cytokines and the pathogenesis of Gaucher's disease: increased release of interleukin 6 and interleukin 10","volume":"90","author":"Allen","year":"1997","journal-title":"QJM"},{"key":"10.1016\/j.ejim.2013.09.006_bb0080","first-page":"205","article-title":"Cytokines in Gaucher's disease","volume":"10","author":"Barak","year":"1999","journal-title":"Eur Cytokine Netw"},{"key":"10.1016\/j.ejim.2013.09.006_bb0085","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1172\/JCI117084","article-title":"Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease","volume":"93","author":"Hollak","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ejim.2013.09.006_bb0090","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1432-1033.1997.00279.x","article-title":"Synthesis, sorting, and processing into distinct isoforms of human macrophage chitotriosidase","volume":"244","author":"Renkema","year":"1997","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.ejim.2013.09.006_bb0095","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.bcmd.2012.04.002","article-title":"Ferritinemia during type 1 Gaucher disease: mechanisms and progression under treatment","volume":"49","author":"Mekinian","year":"2012","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.ejim.2013.09.006_bb0100","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/pbc.22863","article-title":"Immunoglobulin abnormalities and effects of enzyme replacement therapy in children with Gaucher disease","volume":"56","author":"Ar\u0131kan-Ayy\u0131ld\u0131z","year":"2011","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.ejim.2013.09.006_bb0105","doi-asserted-by":"crossref","first-page":"4569","DOI":"10.1182\/blood-2004-12-4672","article-title":"Gaucher disease and Cancer Incidence: a study from the Gaucher Registry","volume":"105","author":"Rosenbloom","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.ejim.2013.09.006_bb0110","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/ajh.20579","article-title":"Unusual severe development of common B lymphoblastic leukemia in Gaucher disease type I","volume":"81","author":"Castelli","year":"2006","journal-title":"Am J Hematol"},{"key":"10.1016\/j.ejim.2013.09.006_bb0545","series-title":"Williams hematology","first-page":"1065","article-title":"Lipid storage diseases","author":"Zimran","year":"2010"},{"key":"10.1016\/j.ejim.2013.09.006_bb0120","first-page":"85","article-title":"Gaucher disease: gene frequencies in the Ashkenazi Jewish population","volume":"52","author":"Beutler","year":"1993","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.ejim.2013.09.006_bb0125","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/00005792-199211000-00002","article-title":"Gaucher disease. Clinical, laboratory, radiologic and genetic features of 53 patients","volume":"71","author":"Zimran","year":"1992","journal-title":"Med (Baltimore)"},{"key":"10.1016\/j.ejim.2013.09.006_bb0130","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1148\/radiology.160.3.3526400","article-title":"Gaucher disease: sonographic appearance of the spleen","volume":"160","author":"Hill","year":"1984","journal-title":"Radiology"},{"key":"10.1016\/j.ejim.2013.09.006_bb0135","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/(SICI)1096-8652(199705)55:1<28::AID-AJH5>3.0.CO;2-5","article-title":"Abdominal ultrasound findings mimicking haematological malignancies in a study of 218 Gaucher patients","volume":"55","author":"Neudorfer","year":"1997","journal-title":"Am J Hematol"},{"key":"10.1016\/j.ejim.2013.09.006_bb0550","first-page":"9","article-title":"The liver in Gaucher disease","volume":"7","author":"Niederau","year":"1999","journal-title":"Gaucher Clin Perspect"},{"key":"10.1016\/j.ejim.2013.09.006_bb0145","first-page":"984","article-title":"Gaucher's disease: a review for the internist and hepatologist","volume":"47","author":"Niederau","year":"2000","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.ejim.2013.09.006_bb0150","first-page":"1","article-title":"Quantitative imagining of the liver and spleen in patients","volume":"3","author":"Chirathivat","year":"1995","journal-title":"Gaucher Clin Perspect"},{"key":"10.1016\/j.ejim.2013.09.006_bb0155","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1006\/bcmd.2001.0480","article-title":"Cholelithiasis in patients with Gaucher disease","volume":"28","author":"Rosenbaum","year":"2002","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.ejim.2013.09.006_bb0160","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s10545-010-9070-1","article-title":"High incidence of cholesterol gallstone disease in type 1 Gaucher disease: characterizing the biliary phenotype of type 1 Gaucher disease","volume":"33","author":"Taddei","year":"2010","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.ejim.2013.09.006_bb0165","first-page":"657","article-title":"Gaucher's disease clinical factures and natural history","volume":"10","author":"Cox","year":"1997"},{"key":"10.1016\/j.ejim.2013.09.006_bb0170","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/1097-0142(19930701)72:1<219::AID-CNCR2820720139>3.0.CO;2-Y","article-title":"Increased risk of cancer in patients with Gaucher disease","volume":"72","author":"Shiran","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.ejim.2013.09.006_bb0175","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1055\/s-2005-871201","article-title":"Gaucher disease: a case report with review of the literature","volume":"25","author":"Xu","year":"2005","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.ejim.2013.09.006_bb0180","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.bcmd.2005.08.004","article-title":"Increased incidence of cancer in adult Gaucher disease in Western Europe","volume":"36","author":"de Fost","year":"2006","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.ejim.2013.09.006_bb0185","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/j.1365-2141.2007.06701.x","article-title":"Recommendations for the management of the haematological and onco-haematological aspects of Gaucher disease","volume":"138","author":"Hughes","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ejim.2013.09.006_bb0190","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1046\/j.1365-2141.1997.d01-2076.x","article-title":"Coagulation abnormalities in type 1 Gaucher disease are due to low-grade activation and can be partly restored by enzyme supplementation therapy","volume":"96","author":"Hollak","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ejim.2013.09.006_bb0195","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1080\/08880010600623232","article-title":"Coagulation abnormalities in type 1 Gaucher disease in children","volume":"23","author":"Deghady","year":"1996","journal-title":"Pediatr Hematol Oncol"},{"key":"10.1016\/j.ejim.2013.09.006_bb0200","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/(SICI)1096-8652(199906)61:2<103::AID-AJH5>3.0.CO;2-V","article-title":"Platelet function abnormalities in Gaucher disease patients","volume":"61","author":"Gillis","year":"1999","journal-title":"Am J Hematol"},{"key":"10.1016\/j.ejim.2013.09.006_bb0205","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1023\/A:1012492429191","article-title":"Clinically relevant therapeutic endpoints in type 1 Gaucher disease","volume":"24","author":"Hollak","year":"2001","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.ejim.2013.09.006_bb0210","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/00005792-198509000-00003","article-title":"Skeletal complication of Gaucher disease","volume":"64","author":"Stowens","year":"1985","journal-title":"Medicine"},{"key":"10.1016\/j.ejim.2013.09.006_bb0215","doi-asserted-by":"crossref","first-page":"A2","DOI":"10.1259\/bjr.75.suppl_1.750002","article-title":"Skeletal aspects of Gaucher disease: a review","volume":"75","author":"Wenstrup","year":"2002","journal-title":"Br J Radiol"},{"key":"10.1016\/j.ejim.2013.09.006_bb0220","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1001\/archinte.160.18.2835","article-title":"The Gaucher registry: demographics and disease characteristics of 1698 patients with Gaucher disease","volume":"160","author":"Charrow","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ejim.2013.09.006_bb0225","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1183\/09031936.96.09020340","article-title":"Pulmonary function abnormalities in type I Gaucher disease","volume":"9","author":"Kerem","year":"1996","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ejim.2013.09.006_bb0230","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1034\/j.1399-0004.2003.00060.x","article-title":"Pulmonary involvement in type I Gaucher disease: functional and exercise findings in patients with and without clinical interstitial lung disease","volume":"63","author":"Miller","year":"2003","journal-title":"Clin Genet"},{"key":"10.1016\/j.ejim.2013.09.006_bb0235","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/S0046-8177(99)90092-8","article-title":"Pulmonary pathology in Gaucher's disease","volume":"30","author":"Armir","year":"1999","journal-title":"Hum Pathol"},{"key":"10.1016\/j.ejim.2013.09.006_bb0240","doi-asserted-by":"crossref","first-page":"901","DOI":"10.7326\/0003-4819-125-11-199612010-00005","article-title":"Pulmonary hypertension developing after alglucerase therapy in two patients with type 1 Gaucher disease complicated by hepatopulmonary syndrome","volume":"125","author":"Dawson","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ejim.2013.09.006_bb0245","doi-asserted-by":"crossref","first-page":"506","DOI":"10.7326\/0003-4819-130-6-199903160-00014","article-title":"Pulmonary hypertension after splenectomy?","volume":"130","author":"Hoeper","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ejim.2013.09.006_bb0250","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S1096-7192(02)00122-1","article-title":"Pulmonary hypertension in type I Gaucher's disease: genetic and epigenetic determinants of phenotype and response to therapy","volume":"77","author":"Mistry","year":"2002","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.ejim.2013.09.006_bb0255","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1136\/pgmj.57.668.398","article-title":"Renal involvement in Gaucher's disease","volume":"57","author":"Siegal","year":"1981","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.ejim.2013.09.006_bb0260","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s11136-004-0794-y","article-title":"Quality of life related to type I Gaucher disease: Spanish experience","volume":"14","author":"Giraldo","year":"2005","journal-title":"Qual Life Res"},{"key":"10.1016\/j.ejim.2013.09.006_bb0265","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.bcmd.2012.11.011","article-title":"Phenotype in patients with Gaucher disease and Parkinson disease","volume":"50","author":"Chetrit","year":"2013","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.ejim.2013.09.006_bb0270","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s10545-010-9055-0","article-title":"The risk of Parkinson's disease in type 1 Gaucher disease","volume":"33","author":"Bultron","year":"2010","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.ejim.2013.09.006_bb0275","first-page":"299","article-title":"Gaucher disease: clinical profile and therapeutic developments","volume":"4","author":"Cox","year":"2010","journal-title":"Biologics"},{"key":"10.1016\/j.ejim.2013.09.006_bb0285","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1034\/j.1399-0004.2001.590511.x","article-title":"Severe valvular and aortic arch calcification in a patient with Gaucher's disease homozygous for the D409H mutation","volume":"59","author":"George","year":"2001","journal-title":"Clin Genet"},{"key":"10.1016\/j.ejim.2013.09.006_bb0290","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/ajh.2830290403","article-title":"Polyclonal B-cell lymphocytosis and hypergammaglobulinemia in patients with Gaucher disease","volume":"29","author":"Marti","year":"1994","journal-title":"Am J Hematol"},{"key":"10.1016\/j.ejim.2013.09.006_bb0295","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00277-008-0441-8","article-title":"Immunoglobulin and free light chain abnormalities in Gaucher disease type I: data from an adult cohort of 63 patients and review of the literature","volume":"87","author":"de Fost","year":"2008","journal-title":"Ann Hematol"},{"key":"10.1016\/j.ejim.2013.09.006_bb0300","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.bcmd.2005.03.004","article-title":"Incidence of malignancies among patients with type I Gaucher disease from a single referral clinic","volume":"34","author":"Zimran","year":"2005","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.ejim.2013.09.006_bb0305","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1136\/fn.82.2.F163","article-title":"Type 2 Gaucher disease: the collodion baby phenotype revisited","volume":"82","author":"Stone","year":"2000","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"10.1016\/j.ejim.2013.09.006_bb0310","author":"International Collaborative Gaucher Group (ICGG)"},{"key":"10.1016\/j.ejim.2013.09.006_bb0315","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1056\/NEJM199111073251906","article-title":"Gaucher disease","volume":"325","author":"Beutler","year":"1991","journal-title":"N Eng J Med"},{"key":"10.1016\/j.ejim.2013.09.006_bb0320","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1258\/000456303766477093","article-title":"Rapid genetic testing for Gaucher disease by reverse hybridization","volume":"40","author":"Halsall","year":"2003","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.ejim.2013.09.006_bb0325","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1089\/gte.1997.1.5","article-title":"Gaucher disease: gene frequencies and genotype\/phenotype correlations","volume":"1","author":"Grabowski","year":"1997","journal-title":"Genet Test"},{"key":"10.1016\/j.ejim.2013.09.006_bb0330","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0009-8981(01)00798-7","article-title":"Gaucher and Niemann\u2013Pick diseases. Enzymatic diagnosis in dried blood spots on filter paper: retrospective diagnosis in newborn-screening cards","volume":"317","author":"Chamoles","year":"2002","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.ejim.2013.09.006_bb0335","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.cca.2008.08.024","article-title":"An improved high-throughput dried blood spot screening method for Gaucher disease","volume":"398","author":"Olivova","year":"2008","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.ejim.2013.09.006_bb0340","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1651-2227.2007.00641.x","article-title":"Biomarkers for lysosomial storage disorders: identification and application as exemplified by chitotriosidase in Gaucher disease","volume":"97","author":"Aerts","year":"2008","journal-title":"Acta Paediatr Suppl"},{"key":"10.1016\/j.ejim.2013.09.006_bb0345","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1080\/08035320510028102","article-title":"Clinical evaluation of biomarkers in Gaucher disease","volume":"94","author":"Deegan","year":"2005","journal-title":"Acta Paediatr Suppl"},{"key":"10.1016\/j.ejim.2013.09.006_bb0350","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s10545-005-0585-9","article-title":"Evaluation of three markers in the monitoring of Gaucher disease","volume":"28","author":"Vellodi","year":"2005","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.ejim.2013.09.006_bb0355","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/ajh.21888","article-title":"A reappraisal of Gaucher disease. Diagnosis and disease management algorithms","volume":"86","author":"Mistry","year":"2011","journal-title":"Am J Hematol"},{"key":"10.1016\/j.ejim.2013.09.006_bb0360","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1007\/s002560100375","article-title":"Magnetic resonance imaging of bone marrow changes in Gaucher disease during enzyme replacement therapy: first German long-term results","volume":"9","author":"Poll","year":"2001","journal-title":"Skeletal Radiol"},{"key":"10.1016\/j.ejim.2013.09.006_bb0365","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s002560000276","article-title":"Bone marrow response in treated patients with Gaucher disease: evaluation by T1-weighted magnetic resonance images and correlation with reduction in liver and spleen volume","volume":"29","author":"Terk","year":"2000","journal-title":"Skeletal Radiol"},{"key":"10.1016\/j.ejim.2013.09.006_bb0370","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1053\/j.seminhematol.2004.07.010","article-title":"Gaucher disease type I: revised recommendations on evaluations and monitoring for adult patients","volume":"41","author":"Weinreb","year":"2004","journal-title":"Semin Hematol"},{"key":"10.1016\/j.ejim.2013.09.006_bb0375","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.cccn.2004.02.018","article-title":"Correlation of surrogate markers of Gaucher disease : implications for long-term follow up of enzyme replacement therapy","volume":"344","author":"Cabrera-Salazar","year":"2004","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.ejim.2013.09.006_bb0380","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1182\/blood-2005-12-5072","article-title":"Superior effect of high-dose enzyme replacement therapy in type 1 Gaucher disease on bone marrow involvement and chitotriosidase levels: a 2-center retrospective analysis","volume":"108","author":"de Fost","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.ejim.2013.09.006_bb0385","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s10545-008-0779-z","article-title":"Management of non-neuronopathic Gaucher disease with special reference to pregnancy, splenectomy, bisphosponate therapy, use of biomarkers and bone disease monitoring","volume":"31","author":"Cox","year":"2008","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.ejim.2013.09.006_bb0390","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.3324\/haematol.12379","article-title":"A new severity score index for phenotypic classification and evaluation of responses to treatment in type I Gaucher disease","volume":"93","author":"Di Rocco","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.ejim.2013.09.006_bb0395","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/S0140-6736(95)91038-7","article-title":"Replacement therapy with imiglucerase for type 1 Gaucher's disease","volume":"345","author":"Zimran","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2013.09.006_bb0400","doi-asserted-by":"crossref","first-page":"33","DOI":"10.7326\/0003-4819-122-1-199501010-00005","article-title":"Enzyme therapy in type 1 Gaucher disease: comparative efficacy of mannose-terminated glucocerebrosidase from natural and recombinant sources","volume":"122","author":"Grabowski","year":"1995","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ejim.2013.09.006_bb0405","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1097\/GIM.0b013e31818e2c19","article-title":"Dose response relationship for enzyme replacement therapy with imiglucerase\/alglucerase in patients with Gaucher disease type 1","volume":"11","author":"Grabowski","year":"2009","journal-title":"Genet Med"},{"key":"10.1016\/j.ejim.2013.09.006_bb0410","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1053\/j.seminhematol.2004.07.009","article-title":"Therapeutic goals in the treatment of Gaucher disease","volume":"41","author":"Pastores","year":"2004","journal-title":"Semin Hematol"},{"key":"10.1016\/j.ejim.2013.09.006_bb0555","series-title":"Business briefing: European pharmacotherapy","article-title":"Gaucher disease-pathophysiology and management of adult patients","author":"Cappellini","year":"2006"},{"key":"10.1016\/j.ejim.2013.09.006_bb0420","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/8904_2012_136","article-title":"Quality of life of Brazilian patients with Gaucher disease and Fabry disease","volume":"7","author":"Oliveira","year":"2013","journal-title":"JIMD Rep"},{"key":"10.1016\/j.ejim.2013.09.006_bb0425","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1056\/NEJM199105233242104","article-title":"Replacement therapy for inherited enzyme deficiency: macrophage-targeted glucocerebrosidase for Gaucher disease","volume":"324","author":"Barton","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2013.09.006_bb0430","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/01.GIM.0000153660.88672.3C","article-title":"Individualization of long-time enzyme replacement therapy for Gaucher disease","volume":"7","author":"Andersson","year":"2005","journal-title":"Genet Med"},{"key":"10.1016\/j.ejim.2013.09.006_bb0435","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.bcmd.2010.10.011","article-title":"Osteopenia in Gaucher disease develops early in life: response to imiglucerase enzyme therapy in children, adolescents and adults","volume":"46","author":"Mistry","year":"2011","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.ejim.2013.09.006_bb0440","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1182\/blood-2011-04-308890","article-title":"How I, treat Gaucher disease","volume":"118","author":"Zimran","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.ejim.2013.09.006_bb0445","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1067\/mpd.2001.112171","article-title":"The efficacy of enzyme replacement therapy in patients with chronic neuronopathic Gaucher's disease","volume":"138","author":"Altarescu","year":"2001","journal-title":"J Pediatr"},{"key":"10.1016\/j.ejim.2013.09.006_bb0450","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1007\/s10545-007-0783-8","article-title":"No justification for very high-dose enzyme therapy for patients with type III Gaucher disease","volume":"30","author":"Zimran","year":"2007","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.ejim.2013.09.006_bb0455","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/0046-8177(95)90097-7","article-title":"Pathological findings in Gaucher disease type 2 patients following enzyme therapy","volume":"26","author":"Bove","year":"1995","journal-title":"Hum Pathol"},{"key":"10.1016\/j.ejim.2013.09.006_bb0460","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.bcmd.2007.02.008","article-title":"A pharmacokinetic analysis of a novel enzyme replacement therapy with Gene-Activated human glucocerebrosidase (GA-GCB) in patients with type I Gaucher disease","volume":"39","author":"Zimran","year":"2007","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.ejim.2013.09.006_bb0465","doi-asserted-by":"crossref","first-page":"4651","DOI":"10.1182\/blood-2010-02-268649","article-title":"Phase 1\u20132 and extension study of velaglucerase alfa replacement therapy in adults with type 1 Gaucher disease: 48-months experience","volume":"115","author":"Zimran","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.ejim.2013.09.006_bb0470","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.bcmd.2010.07.008","article-title":"Early achievement and maintenance of the therapeutic goals using velaglucerase alfa in type 1 Gaucher disease","volume":"46","author":"Elstein","year":"2011","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.ejim.2013.09.006_bb0475","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/j.1467-7652.2007.00263.x","article-title":"Production of glucocerebosidase with terminal mannose glycans for enzyme replacement therapy of Gaucher's disease using a plant cell system","volume":"5","author":"Shaaltiel","year":"2007","journal-title":"Plant Biotechnol J"},{"key":"10.1016\/j.ejim.2013.09.006_bb0480","doi-asserted-by":"crossref","first-page":"e4792","DOI":"10.1371\/journal.pone.0004792","article-title":"A plant-derived recombinant human glucocerebrosidase enzyme- a preclinical and phase I investigation","volume":"4","author":"Aviezer","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.ejim.2013.09.006_bb0485","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/S0140-6736(00)02161-9","article-title":"Novel oral treatment of Gaucher's disease with N-butyldeoxynojirimycin (OGT 918) to decrease substrate biosynthesis","volume":"355","author":"Cox","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2013.09.006_bb0490","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1002\/ana.21491","article-title":"Randomized controlled trial of miglustat in Gaucher's disease type 3","volume":"64","author":"Schiffmann","year":"2008","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ejim.2013.09.006_bb0495","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1023\/B:BOLI.0000045756.54006.17","article-title":"Sustained therapeutic effects of oral miglustat (Zavesca, N-butyldeoxynojirimycin, OGT 918) in type I Gaucher disease","volume":"27","author":"Elstein","year":"2004","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.ejim.2013.09.006_bb0500","doi-asserted-by":"crossref","first-page":"4095","DOI":"10.1182\/blood-2010-06-293902","article-title":"Improvement in haematological, visceral and skeletal manifestations of Gaucher disease type 1 with oral eliglustat tartrate (Genz-112638) treatment: 2-year results of a phase 2 study","volume":"116","author":"Lukina","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.ejim.2013.09.006_bb0505","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1002\/cbic.200800249","article-title":"Isofagomine induced stabilization of glucocerebrosidase","volume":"9","author":"Kornhaber","year":"2008","journal-title":"Chembiochem"},{"key":"10.1016\/j.ejim.2013.09.006_bb0510","series-title":"Gaucher disease. Unimed Science","author":"Niederau","year":"2009"},{"key":"10.1016\/j.ejim.2013.09.006_bb0515","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1051\/jbio\/2002196020175","article-title":"Gene therapy of Gaucher's and Fabry's diseases: current status and prospects","volume":"196","author":"Fabrega","year":"2002","journal-title":"J Soc Biol"},{"key":"10.1016\/j.ejim.2013.09.006_bb0520","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/00003086-199110000-00021","article-title":"Osteoporosis and bone density measurements methods","volume":"271","author":"Ostlere","year":"1991","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.ejim.2013.09.006_bb0525","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1182\/blood-2003-11-3854","article-title":"Gaucher disease: alendronate disodium improves bone mineral density in adults receiving enzyme therapy","volume":"104","author":"Wenstrup","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.ejim.2013.09.006_bb0530","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1016\/S0140-6736(94)90462-6","article-title":"Enzyme replacement treatment in type 1 and type 3 Gaucher's disease","volume":"344","author":"Bembi","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2013.09.006_bb0535","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1054\/arth.2001.19162","article-title":"Outcome of total hip arthroplasty in patients with Gaucher disease","volume":"16","author":"Lebel","year":"2001","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.ejim.2013.09.006_bb0560","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ejogrb.2010.12.024","article-title":"The management of pregnancy in Gaucher disease","volume":"156","author":"Granovsky-Grisaru","year":"2011","journal-title":"Eur J Obstet Gynecol Reprod Biol"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620513009515?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620513009515?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,7]],"date-time":"2022-03-07T13:35:47Z","timestamp":1646660147000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620513009515"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":107,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S0953620513009515"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2013.09.006","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gaucher disease: A diagnostic challenge for internists","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2013.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}